25+ Incredible U.S. Pharmaceutical Statistics [2023] Facts, Data, Trends And More Zippia


Animation Market Forecasted to Reach Value of Around US 642.5 Bn by 2030 Digital Journal

China's biopharma market continues to grow at a healthy pace. Market growth has remained in mid-single figures over recent years, with total value reaching some $130 billion 1 IMS Market Prognosis 2017-2021: China, QuintilesIMS, March 2017. in 2018, making China second only to the United States in world rankings. However, powerful trends are set to transform the industry over the next few years.


US Pharmaceutical Industry Statistics 2023

The industry's value-added output rose 23.1 percent year on year, 13.5 percentage points higher than the overall growth rate, bringing its share in China's total industrial output to 4.1 percent.


Global Pharma Slowdown Impacts China and Japan Brink The Edge of Risk

BEIJING — China's pharmaceutical firms saw their combined business revenue climb 18.7 percent year-on-year in 2021, the highest growth rate in five years, official data showed on May 10. Companies in this sector together raked in 3.37 trillion yuan (about $502 billion) in revenue last year, Zhou Jian, an official with the Ministry of Industry and Information Technology, told a press conference.


Growth Insights on China's Pharmaceutical Industry, Forecast to 2025

50-62. 2027F. Global vaccine market has reached $39 billion in 2022 with a CAGR of 7% between 2017-2022, excluding COVID-19 vaccines. The future market is expected to grow with a CAGR of 5-10% in the next 5 years (till 2027) and to reach $50-62 billion.


China's pharmaceutical industry is poised for major growth

The rapid development of China's pharmaceutical industry in the past five years is also accompanied by bubbles. At the end of 2021, the industry started to face adjustment due to the impact of the pandemic and the economic environment.. In the past five years, the compound annual growth rate of domestic chemical drugs was 15%, and that of.


Construction Chemicals Market Size, Report 20232032

Figure 1 shows some of the key drivers of the healthcare sector in China. The biopharmaceutical market in China is expected to have a compounded annual growth rate (CAGR) of 19.3% over the period of 2015 to 2024, far exceeding the global growth rate of less than 10%, as seen in Figure 1. Fig 1. Market size and compound annual growth rate (CAGR.


Pharma Industry struggles with stagnant growth rate worldwide Source... Download Scientific

Growth rate of pharmaceutical sales value in China 2018-2023. In China, the coronavirus COVID-19 pandemic could cause a prolonged effect in the pharmaceutical market. In 2020, the sales value of.


Global Pharmaceutical Industry Market 2021 FirmsWorld

China's pharmaceutical. by drug companies has drawn attention to the nature of China's pharmaceutical industry. Asia has the world's highest rate of pharmaceutical sales growth, rising at.


25+ Incredible U.S. Pharmaceutical Statistics [2023] Facts, Data, Trends And More Zippia

The pharmaceutical market in China remains strategically important with its predicted growth and market size. It is projected to reach $332Bn by 2022, with a CAGR of ~7% from 2022-25 and the main driving forces behind this growth - aging population and prevalent chronic diseases, wealthy middle-class with higher healthcare demands, and expansion of insurance coverage - still remain.


annualgrowthpharmaceuticalindustry PECB Insights

The pharmaceutical industry is an important part of China's national economy, with continuous strong demand, need, and capability for innovation. The industry continues to experience high levels of growth. With China's increasing emphasis on the pharmaceutical industry, and the gradual improvement of healthcare policies, momentum supporting


Bioassociate Industry Blog 5year plans and Biotech China is an innovator, begins by

The following is an overview of China's status in the most important areas: enablers, value chain capabilities, and innovation. Enablers China and China-originated biotechs have made efforts to bolster enablers for industry growth Methodology This article has both quantitative and qualitative sources. The quantitative


World pharmaceutical market

Looking ahead, the industry is expected to grow at an annual growth rate of 7.22% (CAGR 2024-2028), resulting in a market volume of US$157.30bn by 2028. When compared globally, United States is.


Global Pharmaceuticals Industry Analysis and Trends 2023 NAVADHI Market Research

the prospects for China's pharmaceutical market, and the view extends to all points along the value chain (Figure 2), although the growth pace for each one may vary slightly. Figure 2: Chinese pharmaceutical industry value chain Remark: data with "*" is calculated on the basis of the data from the Sixth National Population Census in 2010.


Global Pharma Slowdown Impacts China and Japan Brink The Edge of Risk

Since joining the World Trade Organization in 2001, China's pharmaceutical industry has experienced remarkable growth. In 2021, it accounted for 12% of the global pharmaceutical market, second only to the United States, which accounted for a substantial 40% of the world's total revenue. By 2022, despite challenges from the COVID-19 pandemic, the industry demonstrated resilience, reaching.


HOW CHINA REGULATORY REFORMS ARE CHANGING THE PHARMACEUTICAL INDUSTRY CSOFT International

Figure 1 shows that the total internal expenditure of R&D and external expenditure of R&D in China's pharmaceutical manufacturing industry showed a year-on-year growth trend from 2012 to 2019. Internal expenditure of R&D increased from 283.31 hundred million yuan in 2012 to 609.56 hundred million yuan in 2019, an increase of 2.15 times and an average annual growth rate of 11.57%.


19 China Cosmetics Industry Statistics and Trends

BEIJING, Oct. 24 -- China's pharmaceutical industry has seen its main business revenues grow at an annual average of 9.3 percent since the beginning of the 14th Five-Year Plan period (2021-2025), the Ministry of Industry and Information Technology (MIIT) said on Tuesday. The sector's combined profits have grown at an annual average of 11.3.